Avenue Therapeutics (ATXI) AGM 2024 summary

Opening remarks and agenda

• The meeting was called to order by the CEO, who welcomed attendees and introduced the board of directors and key participants, including legal counsel and independent auditors.

• The agenda included accepting motions, collecting votes, and reporting results, with instructions for submitting questions online.

Board and executive committee updates

• Directors present included Jay Kranzler, Faith Charles, Neil Herskowitz, Curtis Oltmans, Lindsay A. Rosenwald, and Alexandra MacLean.

Shareholder proposals

• Three motions were presented: election of directors, ratification of KPMG LLP as auditors for 2024, and amendment of the 2015 Incentive Plan to increase authorized shares and extend its term.

• The amendment also increased the annual share limit for non-employee director awards to 500,000.